Viewing Study NCT01571180



Ignite Creation Date: 2024-05-06 @ 12:26 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01571180
Status: UNKNOWN
Last Update Posted: 2017-05-18
First Post: 2012-04-02

Brief Title: Influence of Obesity and Gastric Bypass on Medication Absorption
Sponsor: KU Leuven
Organization: KU Leuven

Study Overview

Official Title: Influence of Obesity and Gastric Bypass on Medication Absorption Prospective Follow-up of Patients
Status: UNKNOWN
Status Verified Date: 2017-05
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: INOGMA
Brief Summary: Patients who have scheduled a gastric bypass RYGB in UZ Leuven will be questioned preoperatively and one three six and twelve months after gastric bypass surgery The purpose of this study is to explore current practice regarding the use of medication and medication counseling after RYGB and to examine the changes in dietary pattern before and after RYGB
Detailed Description: Target group patients who have scheduled a gastric bypass in UZ Leuven Patients will be questioned preoperatively and one three six and twelve months after gastric bypass surgery Each assessment will be performed during a routine consultation

The following aspects will be investigated

Medication The investigators have composed a questionnaire to examine which drugs the patients use adherence information received about medication and from whom
Clinical parameters Every consultation concentrations of hemoglobin iron hepcidin vitamin B12 and a 24h urine collection to determine calcium excretion will be collected
Dietary intake The investigators will ask patients to keep a food record during two non-consecutive days preceding each consultation In this food record patients have to note all consumed foods and beverages with the rightestimated amounts This makes it possible to see the changes of the composition of the meals before and after RYGB
Body composition

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None